Synthesis and crystal structure of 3-N-acetyl-5-(pyridin-3-yl)-2-(quinolin-2-yl)-1,3,4-oxadiazoline, C18H14N4O2
C18H14N4O2, triclinic, P1̄ (no. 2), a = 7.6557(7) Å, b = 11.0905(8) Å, c = 11.3544(9) Å, α = 61.6430(10)°, β = 73.600(2)°, γ = 75.397(2)°, V = 805.86(11) Å3, Z = 2, Rgt(F) = 0.0609, wRref(F2) = 0.1633, T = 298 K.
Main Authors: | Yu Xiang, Peng Lu, Wang Xin, Chen Ya-Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-08-01
|
Series: | Zeitschrift für Kristallographie - New Crystal Structures |
Subjects: | |
Online Access: | https://doi.org/10.1515/ncrs-2020-0174 |
Similar Items
-
Crystal structure of 1-(2-(pyridin-2-yl)-5-(pyridin-3-yl)-1,3,4-oxadiazol-3(2H)-yl)ethan-1-one, C14H12N4O2
by: Yu Xiang, et al.
Published: (2020-08-01) -
Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines: Synthesis and Biological Activity
by: Kinga Paruch, et al.
Published: (2020-12-01) -
Biological Activity, Lipophilicity and Cytotoxicity of Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines
by: Kinga Paruch, et al.
Published: (2021-12-01) -
N-(5-Ethylsulfanyl-1,3,4-thiadiazol-2-yl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)acetamide
by: Shuang Zhi, et al.
Published: (2011-06-01) -
Crystal structure of 2-(5-(pyridin-3-yl)-4-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine, C17H12N6
by: Sun Hongtao, et al.
Published: (2020-08-01)